Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

SEC Filing Details

Document Details

Form
Filing Date
October 13, 2026
Document Date
September 4, 2026
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Tarsus Pharmaceuticals
Issuer
TARSUS PHARMACEUTICALS, INC.